U tijeku je upis prve generacije polaznika Sveučilišnog poslijediplomskog specijalističkog studija “Internistička onkologija” .
Stručni studij
HLZ- ESMO RSS
- Significantly Longer PFS with First-line Pembrolizumab for MSI-H/dMMR mCRC 3. prosinca 2020.
- Keeping progress in oncology on the agenda: ESMO honours recipients of its 2020 awards 3. prosinca 2020.
- FDA Approves Pralsetinib for RET-Altered Thyroid Cancers 2. prosinca 2020.
- FDA Approves Device for Treatment of Osteoid Osteoma in the Extremities 1. prosinca 2020.
- First Global Estimates of Cervical Cancer Attributable to HIV 30. studenoga 2020.
